NeuroGeneces:

Making Brain Health More Accessible

by Sade Smith

  • Company:  NeuroGeneces, Inc
  • Founded:  2021
  • Location: Santa Fe, NM
  • Founder(s):  Karen Crow,  Dr. Jason Worchel
  • Focus Area:  Preventive Brain Health
  • Technology/Product:  NeuroInsight
  • Stage: Research / Development / Commercialization / Growth
  • Website:  https://www.neurogeneces.com/
  • Looking for: Funding / Research Partners / Industry Partners / Talent / Customers/ Other

Routine health screenings have become an important part of maintaining overall wellness. Blood work and screenings for heart disease and colorectal cancer help individuals monitor their health and identify potential concerns early. Yet brain health is often overlooked. Unlike other aspects of physical health, brain function is rarely evaluated unless symptoms arise. And when it is, results are often presented through complex imaging and technical medical language that can be difficult for patients to understand.

Santa Fe-based neurotechnology company NeuroGeneces is actively working to change this.

After watching a parent struggle with Alzheimer’s disease, company co-founder, Karen Crow, recognized a significant gap in preventative healthcare: there is no widely accessible, practical way to monitor how the brain is functioning over time. As concerns about cognitive health and aging continue to grow, Crow saw an opportunity to make brain health more accessible and understandable.

According to the 2024 Lancet Commission Report on Dementia, addressing 14 modifiable risk factors could potentially delay or prevent approximately 45% of dementia cases. However, many existing clinical assessments, including MRI scans, blood biomarkers, and genetic testing, focus on specific risk factors or indicators rather than providing an accessible picture of overall brain function.

[New Mexico] has a unique combination of scientific talent, research institutions, national laboratories, and a supportive entrepreneurial community.

Karen Crow

Co-Founder, NeuroGeneces

To help bridge this gap, Crow partnered with co-founder, Jason Worchel, MD, to develop technology designed to make brain health assessments more accessible. Their first product, NeuroInsight®, is an at-home assessment that measures the brain’s electrical activity during sleep to estimate an individual’s “Functional Brain Age.”

Using a forehead patch, the device captures electrical signals generated by neurons as they communicate. Sophisticated algorithms analyze more than 400 features of brain activity and compare them with recordings from thousands of healthy individuals across different age groups.

The result is a single, objective metric: Functional Brain Age. By translating complex neuroscience data into an understandable measure, NeuroInsight® gives individuals a way to establish a baseline and monitor changes in their brain function over time.

NeuroGeneces takes a preventative approach to brain health, with the goal of helping individuals better understand their brain function before cognitive symptoms emerge. Crow says the company’s initial focus is on “adults between 40 and 70 who are interested in protecting their long-term cognitive health.”

The idea is to give people who are already taking steps to maintain their physical health another tool to support their overall wellness. With access to this information, individuals and healthcare providers may be better equipped to identify opportunities for proactive lifestyle changes.

As Crow explains, the co-founders believe that “making brain function visible can be a powerful motivator for sustained behavior change.”

NeuroInsight®

New Mexico’s rich scientific landscape has also made it an ideal environment for NeuroGeneces to grow. As Crow notes, “The state has a unique combination of scientific talent, research institutions, national laboratories, and a supportive entrepreneurial community.”

Through relationships with Sandia National Laboratories, New Mexico Angels, New Mexico Startup Alliance, and NM Venture Builders, NeuroGeneces has developed a strong network of support as it advances its technology.

The company has also received funding from the National Institutes of Health (NIH), National Science Foundation (NSF), and Department of Defense (DOD). This support has helped advance its research, including four IRB-approved clinical studies, secure three U.S. patents, and complete key product certifications.

Today, NeuroGeneces is building on that foundation through research collaborations with The University of California at San Francisco, The University of New Mexico, and the University of Miami.

“After years focused on research, engineering, and clinical validation, we’re entering an exciting new phase: putting our technology into the hands of patients and physicians and learning how Functional Brain Age feedback can support real-world behavior change,” says Crow.

As the company moves into this next phase, NeuroGeneces hopes its technology will contribute to a broader understanding of brain health and support efforts to prevent and address cognitive decline.

To advance this work, the company is looking to connect with concierge physicians, preventative medicine practices, longevity clinics, and organizations focused on helping people make sustainable lifestyle changes. The team is also pursuing additional clinical, commercial, and research partnerships.

By bringing together neuroscience, consumer health, and preventative care, NeuroGeneces is working to make brain health a more visible and accessible part of the conversation around lifelong wellness.

To learn more about NeuroGeneces and its NeuroInsight® technology, visit NeuroGeneces.com.

The owner of this website has made a commitment to accessibility and inclusion, please report any problems that you encounter using the contact form on this website. This site uses the WP ADA Compliance Check plugin to enhance accessibility.